Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Germany cancer and oncology drugs tenders

Get access to latest Germany cancer oncology drugs tenders and government contracts. Find business opportunities for Germany cancer drugs tenders, Germany oncology drugs tenders, Germany cancer treatment drugs tenders.

Summary:
Ex-Ante Transparency Announcement Contract According To § 130C Sgb V Drug Tremfya (R) Active Ingredient: Guselkumab Atc Code: L04Ac16
Country:
Germany
 
Notice Type:
Procurement Plan
Deadline:
18 Apr 2025
Posting Date:
23 Apr 2024
 
 
 
Summary:
31St Generic Tender (1B)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
28 May 2024
Posting Date:
23 Apr 2024
 
 
 
Summary:
Medicines With The Active Ingredient Combination Formoterol, Glycopyrronium Bromide And Beclometasone (Atc: R03Al09)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Mar 2026
Posting Date:
23 Apr 2024
 
 
 
Summary:
Medicines With The Active Ingredient Dupilumab (Atc: D11Ah05)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Mar 2026
Posting Date:
23 Apr 2024
 
 
 
Summary:
31St Generic Tender (1A)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
28 May 2024
Posting Date:
23 Apr 2024
 
 
 
Summary:
Framework Agreement On The Supply Of Lower Saxony'S Correctional Facilities (Excluding Correctional Hospitals) With Medicines, Medical Consumables, Medical Devices.
Country:
Germany
Estimated Cost:
EUR 8640000
Notice Type:
Tender Notice
Deadline:
06 May 2024
Posting Date:
23 Apr 2024
 
 
 
Summary:
Nuclear Medicine Avs
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
27 May 2024
Posting Date:
23 Apr 2024
 
 
 
Summary:
Medicines With The Active Ingredient Fampridine (Atc: N07Xx07)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Mar 2026
Posting Date:
22 Apr 2024
 
 
 
Summary:
Medicines With The Active Ingredient Combination Vilanterol, Umeclidinium Bromide And Fluticasone Furoate (Atc: R03Al08)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Mar 2026
Posting Date:
22 Apr 2024
 
 
 
Summary:
Medicines With The Active Ingredient Tiotropium Bromide (Atc: R03Bb04 - Except In The Dosage Form Hard Capsules With Powder For Inhalation)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Mar 2026
Posting Date:
22 Apr 2024